Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: APOLIPOPROTEINS, . Treffer: 74

2019

Blom, WAM; Koppenol, WP; Hiemstra, H; Stojakovic, T; Scharnagl, H; Trautwein, EA A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia.
Eur J Nutr. 2019; 58(4):1615-1624 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hollstein, T; Vogt, A; Grenkowitz, T; Stojakovic, T; März, W; Laufs, U; Bölükbasi, B; Steinhagen-Thiessen, E; Scharnagl, H; Kassner, U Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.
Vascul Pharmacol. 2019; 116:8-15
Web of Science PubMed FullText FullText_MUG

 

Roula, D; Theiler, A; Luschnig, P; Sturm, GJ; Tomazic, PV; Marsche, G; Heinemann, A; Sturm, EM Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naïve allergic patients and allergen-challenged mice.
Allergy. 2019; [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Kober, AC; Manavalan, APC; Tam-Amersdorfer, C; Holmér, A; Saeed, A; Fanaee-Danesh, E; Zandl, M; Albrecher, NM; Björkhem, I; Kostner, GM; Dahlbäck, B; Panzenboeck, U Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier.
Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862(6):573-588
Web of Science PubMed FullText FullText_MUG

 

März, W; Grammer, TB; Delgado, G; Kleber, ME [Congenital disorders of lipoprotein metabolism].
Herz. 2017; 42(5):449-458 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Pertl, L; Kern, S; Weger, M; Hausberger, S; Trieb, M; Gasser-Steiner, V; Haas, A; Scharnagl, H; Heinemann, A; Marsche, G High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration.
PLoS One. 2016; 11(5):e0154397-e0154397 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Almer, G; Mangge, H; Zimmer, A; Prassl, R Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.
Curr Med Chem. 2015; 22(31):3631-3651 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tomazic, PV; Birner-Gruenberger, R; Leitner, A; Darnhofer, B; Spoerk, S; Lang-Loidolt, D Apolipoproteins have a potential role in nasal mucus of allergic rhinitis patients: a proteomic study.
Laryngoscope. 2015; 125(3):E91-E96
Web of Science PubMed FullText FullText_MUG

 

2014

Tomazic, PV; Birner-Gruenberger, R; Leitner, A; Obrist, B; Spoerk, S; Lang-Loidolt, D Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis.
J Allergy Clin Immunol. 2014; 133(3):741-750
Web of Science PubMed FullText FullText_MUG

 

Wree, A; Schlattjan, M; Bechmann, LP; Claudel, T; Sowa, JP; Stojakovic, T; Scharnagl, H; Köfeler, H; Baba, HA; Gerken, G; Feldstein, AE; Trauner, M; Canbay, A Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
Metabolism. 2014; 63(12):1542-1552
Web of Science PubMed FullText FullText_MUG

 

2012

Chennamsetty, I; Claudel, T; Kostner, KM; Trauner, M; Kostner, GM FGF19 signaling cascade suppresses APOA gene expression.
Arterioscler Thromb Vasc Biol. 2012; 32(5):1220-1227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Kratzer, I; Wernig, K; Panzenboeck, U; Bernhart, E; Reicher, H; Wronski, R; Windisch, M; Hammer, A; Malle, E; Zimmer, A; Sattler, W Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
J Control Release. 2007; 117(3): 301-311. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nohara, A; Kawashiri, MA; Claudel, T; Mizuno, M; Tsuchida, M; Takata, M; Katsuda, S; Miwa, K; Inazu, A; Kuipers, F; Kobayashi, J; Koizumi, J; Yamagishi, M; Mabuchi, H High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Arterioscler Thromb Vasc Biol. 2007; 27(4): 923-928. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; März, W; Winkelmann, BR; Boehm, BO; Schmut, O Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion.
CLIN CHIM ACTA. 2007; 382(1-2): 77-81.
Web of Science PubMed FullText FullText_MUG

 

2005

Rothenbacher, D; Brenner, H; März, W; Koenig, W Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Eur Heart J. 2005; 26(16):1640-1646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Scharnagl, H; Kist, M; Grawitz, AB; Koenig, W; Wieland, H; März, W Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol.
Am J Cardiol. 2004; 93(2):219-220
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Scharnagl, H; Winkler, K; Mantz, S; Baumstark, MW; Wieland, H; März, W Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.
Exp Clin Endocrinol Diabetes. 2004; 112(5):269-277
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Wetzka, B; Hoffmann, MM; Friedrich, I; Baumstark, MW; Zahradnik, HP; März, W; Winkler, K Transient remnant removal disease in acute fatty liver of pregnancy.
Hypertens Pregnancy. 2004; 23(2):143-153 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Bräsen, JH; Häkkinen, T; Malle, E; Beisiegel, U; Ylä-Herttuala, S Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits.
Atherosclerosis. 2003; 166(1):13-21
Web of Science PubMed FullText FullText_MUG

 

2002

Abletshauser, C; Klüssendorf, D; Schmidt, A; Winkler, K; März, W; Buddecke, E; Malmsten, M; Siegel, G Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor.
Acta Physiol Scand. 2002; 176(2):131-145
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Gander, R; Eller, P; Kaser, S; Theurl, I; Walter, D; Sauper, T; Ritsch, A; Patsch, JR; Föger, B Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein.
J Lipid Res. 2002; 43(4):636-645 [OPEN ACCESS]
Web of Science PubMed

 

Wiemer, J; Winkler, K; Baumstark, M; März, W; Scherberich, JE Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses.
Nephrol Dial Transplant. 2002; 17(12):2231-2238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Hoffmeister, A; Rothenbacher, D; Bode, G; Persson, K; März, W; Nauck, MA; Brenner, H; Hombach, V; Koenig, W Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.
Arterioscler Thromb Vasc Biol. 2001; 21(3): 427-432. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

März, W; Scharnagl, H; Abletshauser, C; Hoffmann, MM; Berg, A; Keul, J; Wieland, H; Baumstark, MW Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.
CIRCULATION 2001 103: 1942-1948. [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Masana, L; Febrer, G; Cavanna, J; Baroni, MG; Marz, W; Hoffmann, MM; Shine, B; Galton, DJ Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
Clin Sci (Lond). 2001; 100(2):183-190 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ohm, TG; Hamker, U; Cedazo-Minguez, A; Röckl, W; Scharnagl, H; März, W; Cowburn, R; Müller, W; Meske, V Apolipoprotein E and beta A4-amyloid: signals and effects.
Biochem Soc Symp. 2001; 68(67):121-129
Web of Science PubMed Google Scholar

 

2000

Böttcher, A; Schlosser, J; Kronenberg, F; Dieplinger, H; Knipping, G; Lackner, KJ; Schmitz, G Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions.
J Lipid Res. 2000; 41(6):905-915 [OPEN ACCESS]
Web of Science PubMed FullText

 

Cerne, D; Kaplan-Pavlovcic, S; Kranjec, I; Jurgens, G Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis.
Ren Fail. 2000; 22(6):799-808 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Cerne, D; Ledinski, G; Kager, G; Greilberger, J; Wang, X; Jürgens, G Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio.
CLIN CHEM LAB MED 2000 38: 529-538.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Panzenböck, U; Kritharides, L; Raftery, M; Rye, KA; Stocker, R Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
J Biol Chem. 2000; 275(26): 19536-19544. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schuler-Lüttmann, S; Zhu, Y; Hoffmann, M; März, W; Feussner, G; Wieland, H; Assmann, G; von Eckardstein, A Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas.
Metabolism. 2000; 49(6):770-777
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Malle, E; Leonhard, B; Knipping, G; Sattler, W Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells.
Scand J Immunol. 1999; 50(2):183-187
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Wetzka, B; Winkler, K; Kinner, M; Friedrich, I; März, W; Zahradnik, HP Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth.
Semin Thromb Hemost. 1999; 25(5):455-462
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Greilberger, J; Jürgens, G Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Biochem J. 1998; 331 ( Pt 1)(2):185-191 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Nielsen, LB; Véniant, M; Borén, J; Raabe, M; Wong, JS; Tam, C; Flynn, L; Vanni-Reyes, T; Gunn, MD; Goldberg, IJ; Hamilton, RL; Young, SG Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins.
Circulation. 1998; 98(1): 13-16. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1997

Schmidt, R; Schmidt, H; Fazekas, F; Schumacher, M; Niederkorn, K; Kapeller, P; Weinrauch, V; Kostner, GM Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.
Stroke. 1997; 28(5):951-956 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Malle, E; De Beer, FC Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice.
Eur J Clin Invest. 1996; 26(6):427-435
Web of Science PubMed FullText FullText_MUG

 

Malle, E; Pfeiffer, KP; Dugi, K; Pfeiffer, C; Glaum, M; Oezcueruemez, M; Kloer, HU; Steinmetz, A Polymorphisms of apolipoproteins A-IV and E in a Turkish population living in Germany.
Hum Genet. 1996; 98(3):285-290
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Nauck, M; März, W; Haas, B; Wieland, H Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated.
Clin Chem. 1996; 42(3):424-429 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Winkelmann, BR; Nauck, M; Klein, B; Russ, AP; Böhm, BO; Siekmeier, R; Ihnken, K; Verho, M; Gross, W; März, W Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
Ann Intern Med. 1996; 125(1):19-25 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Gorges, R; Hofer, G; Sommer, A; Stütz, H; Grillhofer, H; Kostner, GM; Paltauf, F; Hermetter, A Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lpa and LDL.
J Lipid Res. 1995; 36(2):251-259 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

Jürgens, G; Taddei-Peters, WC; Költringer, P; Petek, W; Chen, Q; Greilberger, J; Macomber, PF; Butman, BT; Stead, AG; Ransom, JH Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
Stroke. 1995; 26(10):1841-1848 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kuhl, H; Jung-Hoffmann, C; Fitzner, M; März, W; Gross, W Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel.
Horm Res. 1995; 44(3): 121-125.
Web of Science PubMed FullText FullText_MUG

 

Meusel, M; Renneberg, R; Spener, F; Schmitz, G Development of a heterogeneous amperometric immunosensor for the determination of apolipoprotein E in serum.
Biosens Bioelectron. 1995; 10(6-7):577-586
Web of Science PubMed FullText FullText_MUG

 

Nauck, M; Winkler, K; Wittmann, C; Mayer, H; Luley, C; März, W; Wieland, H Direct determination of lipoprotein(a) cholesterol by ultracentrifugation and agarose gel electrophoresis with enzymatic staining for cholesterol.
Clin Chem. 1995; 41(5):731-738 [OPEN ACCESS]
Web of Science PubMed

 

1994

Haak, T; März, W; Jungmann, E; Hausser, S; Siekmeier, R; Gross, W; Usadel, KH Elevated endothelin levels in patients with hyperlipoproteinemia.
Clin Investig. 1994; 72(8):580-584
Web of Science PubMed Google Scholar

 

März, W; Grützmacher, P; Paul, D; Siekmeier, R; Schoeppe, W; Gross, W Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
Int J Clin Pharmacol Ther. 1994; 32(2):92-97
Web of Science PubMed Google Scholar

 

1993

Birchbauer, A; Knipping, G; Juritsch, B; Aschauer, H; Zechner, R Characterization of the apolipoprotein AI and CIII genes in the domestic pig.
GENOMICS. 1993; 15(3): 643-652.
Web of Science PubMed FullText FullText_MUG

 

Malle, E; Steinmetz, A; Raynes, JG Serum amyloid A (SAA): an acute phase protein and apolipoprotein.
ATHEROSCLEROSIS. 1993; 102(2): 131-146.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

März, W; Feussner, G; Siekmeier, R; Donnerhak, B; Schaaf, L; Ruzicka, V; Gross, W Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinaemia.
Eur J Clin Chem Clin Biochem. 1993; 31(11):743-747
Web of Science PubMed Google Scholar

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum